These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of the androgen receptor/filamin a complex in stromal cells. Giovannelli P; Di Donato M; Auricchio F; Castoria G Methods Mol Biol; 2014; 1204():109-21. PubMed ID: 25182765 [TBL] [Abstract][Full Text] [Related]
4. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells. Di Donato M; Giovannelli P; Barone MV; Auricchio F; Castoria G; Migliaccio A Cells; 2021 Dec; 11(1):. PubMed ID: 35011576 [TBL] [Abstract][Full Text] [Related]
5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation. Fang Z; Zhang T; Dizeyi N; Chen S; Wang H; Swanson KD; Cai C; Balk SP; Yuan X J Biol Chem; 2012 Jan; 287(3):2090-8. PubMed ID: 22139837 [TBL] [Abstract][Full Text] [Related]
7. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells. Ye D; Mendelsohn J; Fan Z Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102 [TBL] [Abstract][Full Text] [Related]
8. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; Bottero D; Vitale F; Migliaccio A; Auricchio F J Cell Biol; 2003 May; 161(3):547-56. PubMed ID: 12743104 [TBL] [Abstract][Full Text] [Related]
9. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Kokontis JM; Hay N; Liao S Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399 [TBL] [Abstract][Full Text] [Related]
10. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells. Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor activation reduces the endothelial cell proliferation through activating the cSrc/AKT/p38/ERK/NFκB-mediated pathway. Huo YN; Yeh SD; Lee WS J Steroid Biochem Mol Biol; 2019 Nov; 194():105459. PubMed ID: 31470108 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation. Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613 [TBL] [Abstract][Full Text] [Related]
13. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Bonaccorsi L; Muratori M; Carloni V; Marchiani S; Formigli L; Forti G; Baldi E Steroids; 2004 Aug; 69(8-9):549-52. PubMed ID: 15288768 [TBL] [Abstract][Full Text] [Related]
14. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Lu S; Tsai SY; Tsai MJ Cancer Res; 1997 Oct; 57(20):4511-6. PubMed ID: 9377562 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
16. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Xu Y; Chen SY; Ross KN; Balk SP Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines. Ramamurthy VP; Ramalingam S; Gediya L; Kwegyir-Afful AK; Njar VC Oncotarget; 2015 Feb; 6(5):3195-210. PubMed ID: 25605250 [TBL] [Abstract][Full Text] [Related]
19. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608 [TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]